Literature DB >> 18922036

Semisynthesis and antiplasmodial activity of the quinoline alkaloid aurachin E.

Gerhard Höfle1, Bettina Bööhlendorf, Thomas Fecker, Florenz Sasse, Brigitte Kunze.   

Abstract

A one-step synthesis of the rare aurachin E (1) from the easily accessible aurachin C (2) and cyanogen bromide is described. 3-Bromocarbamoylquinoline (5) is formed in a side reaction with concomitant loss of the 3-farnesyl residue. In an alternative approach, aurachin D (3) was reacted with phosgene and sodium azide to form the imidazolone ring of 1 via N-acylation. Unexpectedly, the initial reaction occurred at the carbonyl group of 3 to give 1H-pyrrolo[3,2-c]quinoline 4. The reaction sequence represents a novel route to this type of compound. Aurachin E, contrary to other aurachins, combines a high in vitro antiplasmodial activity with low cytotoxicity and absence of mitochondrial respiratory inhibition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18922036     DOI: 10.1021/np8004612

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  7 in total

1.  Close the ring to break the cycle: tandem quinolone-alkyne-cyclisation gives access to tricyclic pyrrolo[1,2-a]quinolin-5-ones with potent anti-protozoal activity.

Authors:  Dávid Szamosvári; Kayla Sylvester; Philipp Schmid; Kuan-Yi Lu; Emily R Derbyshire; Thomas Böttcher
Journal:  Chem Commun (Camb)       Date:  2019-06-13       Impact factor: 6.222

2.  Biological assay of a novel quinoxalinone with antimalarial efficacy on Plasmodium yoelii yoelii.

Authors:  Norma Rivera; Yovani Marrero Ponce; Vicente J Arán; Cecilia Martínez; Filiberto Malagón
Journal:  Parasitol Res       Date:  2013-01-22       Impact factor: 2.289

3.  Identification, design and biological evaluation of bisaryl quinolones targeting Plasmodium falciparum type II NADH:quinone oxidoreductase (PfNDH2).

Authors:  Chandrakala Pidathala; Richard Amewu; Bénédicte Pacorel; Gemma L Nixon; Peter Gibbons; W David Hong; Suet C Leung; Neil G Berry; Raman Sharma; Paul A Stocks; Abhishek Srivastava; Alison E Shone; Sitthivut Charoensutthivarakul; Lee Taylor; Olivier Berger; Alison Mbekeani; Alasdair Hill; Nicholas E Fisher; Ashley J Warman; Giancarlo A Biagini; Stephen A Ward; Paul M O'Neill
Journal:  J Med Chem       Date:  2012-02-24       Impact factor: 7.446

Review 4.  Bacterial terpenome.

Authors:  Jeffrey D Rudolf; Tyler A Alsup; Baofu Xu; Zining Li
Journal:  Nat Prod Rep       Date:  2021-05-26       Impact factor: 15.111

5.  Short-chain aurachin D derivatives are selective inhibitors of E. coli cytochrome bd-I and bd-II oxidases.

Authors:  Melanie Radloff; Isam Elamri; Tamara N Grund; Luca F Witte; Katharina F Hohmann; Sayaka Nakagaki; Hojjat G Goojani; Hamid Nasiri; Dirk Bald; Hao Xie; Junshi Sakamoto; Harald Schwalbe; Schara Safarian
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

6.  Synthesis and biological activities of the respiratory chain inhibitor aurachin D and new ring versus chain analogues.

Authors:  Xu-Wen Li; Jennifer Herrmann; Yi Zang; Philippe Grellier; Soizic Prado; Rolf Müller; Bastien Nay
Journal:  Beilstein J Org Chem       Date:  2013-07-31       Impact factor: 2.883

7.  Biosynthetic Plasticity Enables Production of Fluorinated Aurachins.

Authors:  Angela Sester; Katrin Stüer-Patowsky; Wolf Hiller; Florian Kloss; Stephan Lütz; Markus Nett
Journal:  Chembiochem       Date:  2020-05-05       Impact factor: 3.164

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.